In a staged play designed to give cover both to President Trump and Big Pharma, Pfizer has announced a temporary roll back of its extortionate price hikes on 41 medicines averaging nearly 9% over and above its existing monopoly prices.  A scene-by-scene recap reveals the cozy, mutually beneficial farce that Trump and Pfizer are enacting. Scene One:  Drug companies like Pfizer use their patent and data-protection monopolies to set prices at whatever the market will bear, with U.S. purchasers paying nearly twice as much as is paid in countries with more rational approaches to trying to prevent abusive pricing.